PubMed=2790824
Klominek J., Robert K.-H., Hjerpe A., Wickstrom B., Gahrton G.
Serum-dependent growth patterns of two, newly established human mesothelioma cell lines.
Cancer Res. 49:6118-6122(1989)

PubMed=7662316; DOI=10.1139/o95-007
Tzanakakis G.N., Karamanos N.K., Klominek J., Hjerpe A.
Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis.
Biochem. Cell Biol. 73:59-66(1995)

PubMed=9310181; DOI=10.1016/S0300-9084(97)80026-0
Tzanakakis G.N., Hjerpe A., Karamanos N.K.
Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway.
Biochimie 79:323-332(1997)

PubMed=23840376; DOI=10.1371/journal.pone.0065903; PMCID=PMC3688685
Szulkin A., Nilsonne G., Mundt F., Wasik A.M., Souri P., Hjerpe A., Dobra K.
Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.
PLoS ONE 8:e65903.1-e65903.14(2013)

PubMed=33567673; DOI=10.3390/cancers13040685; PMCID=PMC7915464
Keller M., Reis K., Hjerpe A., Dobra K., Aspenstrom P.
Cytoskeletal organization correlates to motility and invasiveness of malignant mesothelioma cells.
Cancers (Basel) 13:685.1-685.20(2021)